LOGENEX has been developing a high competence in out-licensing and supplying its pharmaceutical products to generic companies in Europe and beyond.
Our licensing partners benefit from:
- Available registration dossiers in CTD-format
- Access to EU-Marketing Authorizations
- Experienced regulatory support
- High product quality and safety
- Customized business models
- Reliable and cost-effective supply chains
LOGENEX Pharm collaborates succesfully with licensing partners in various international markets. Today, our generics are approved and sold in more than 25 countries across Europe, Middle East/North Africa, Asia and Latin America.